Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Z Shomanova"'
Publikováno v:
Българска кардиология, Vol 30, Iss 2, Pp 120-131 (2024)
The follow-up of pregnant patients with cardiomyopathies is a challenge that every cardiologist will be facing sooner or later. We present the first case of a patient with restrictive cardiomyopathy and Alpha-B-crystallinopathy (distal myopathy type)
Externí odkaz:
https://doaj.org/article/fb79e33315c24259887421f8c96ad904
Publikováno v:
Българска кардиология, Vol 30, Iss 2, Pp 132-137 (2024)
Mitochondrial diseases are rare and heterogeneous conditions frequently affecting the heart. They are caused by mutations in nuclear or mitochondrial DNA with maternal inheritance or de novo occurrence. We present a case of 13-year-old girl with mali
Externí odkaz:
https://doaj.org/article/80f05e6c75c74167879bab6cde6b0fef
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P Jirak, V Van Almsick, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, D Semo, D Dankl, M Mahringer, M Lichtenauer, U Hoppe, H Reinecke, R Pistulli, R Larbig, L Motloch
Publikováno v:
European Heart Journal. 43
Background Severe COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease. However, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0514d60fc54afa2d20da7c0ae80a604
https://doi.org/10.1093/eurheartj/ehac544.1478
https://doi.org/10.1093/eurheartj/ehac544.1478
Autor:
V Van Almsick, P Jirak, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, D Semo, D Dankl, M Mahringer, M Lichtenauer, U Hoppe, H Reinecke, R Larbig, L Motloch, R Pistulli
Publikováno v:
European Heart Journal. 43
Aims/Background Severe COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccb9b65e1714fafce3feb5c0c4cd67af
https://doi.org/10.1093/eurheartj/ehac544.1271
https://doi.org/10.1093/eurheartj/ehac544.1271
Autor:
T Froehling, M Mirna, V Paar, Z Shomanova, V Van Almsick, L J Motloch, D Semo, L Makowski, A Rukosujew, J R Sindermann, H Reinecke, M Lichtenauer, R Pistulli
Publikováno v:
European Heart Journal. 43
Aims Heart failure (HF) remains a major therapeutic and diagnostic challenge. In this study we aimed to analyze the predictive potential of four novel cardiovascular biomarkers – soluble urokinase-type plasminogen activator receptor (suPAR), vascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c68250125910d5377e92a00f8ea4f023
https://doi.org/10.1093/eurheartj/ehac544.911
https://doi.org/10.1093/eurheartj/ehac544.911
Autor:
B Ohnewein, Z Shomanova, P Jirak, A Topf, E J Froeb, C Pogoda, C Granitz, M Lichtenauer, U Hoppe, H Reinecke, R Pistulli, L J Motloch
Publikováno v:
European Heart Journal. 43
Background Heart Failure with reduced ejection fraction (HFrEF) has a life time risk about 20% among adults aged 40 years or older and a 5-year mortality rate about 60% [1,2]. However novel therapies have shown to improve this outcome. One novel agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e151bd8cab03cc22360b40a899d722a
https://doi.org/10.1093/eurheartj/ehac544.974
https://doi.org/10.1093/eurheartj/ehac544.974
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniel Dankl, Robert Larbig, P Jirak, Rudin Pistulli, Jürgen R. Sindermann, Uta C. Hoppe, Lukas J. Motloch, Michael Lichtenauer, D. Butkiene, B Strohmer, Z. Shomanova, C Seelmaier, N. Frank, J. Sackarnd, Holger Reinecke
Publikováno v:
European Heart Journal
Background Thromboembolic events, including stroke, are typical complications of COVID-19. Whether arrhythmias, frequently described in severe COVID-19, are disease-specific and thus promote strokes is unclear. We investigated the occurrence of arrhy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b87fe7142cfe87dab03d7d2bab7123
https://doi.org/10.1093/eurheartj/ehab724.0287
https://doi.org/10.1093/eurheartj/ehab724.0287
Autor:
P Jirak, Lukas J. Motloch, Z. Shomanova, Rudin Pistulli, C Granitz, Uta C. Hoppe, Holger Reinecke, B Ohnewein, C.A Pogoda, Michael Lichtenauer, E.J Froeb
Publikováno v:
European Heart Journal. 41
Aims Leptin has recently been related to myocardial remodeling in animal experimentation studies on heart failure (HF). Furthermore, leptin has been reported to be related to diastolic dysfunction, however only in healthy population. With the emergen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7c0bca82208f1f1ee7236c9e5e597d7
https://doi.org/10.1093/ehjci/ehaa946.0915
https://doi.org/10.1093/ehjci/ehaa946.0915